Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ARGX | argenx SE | 2.43% | 373.33 | 0.0% | $115.77m | |
| ICLR | ICON plc | -1.05% | 216.80 | 2.8% | $111.55m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -4.65% | 8.42 | 14.1% | $49.54m | |
| RVMD | Revolution Medicines, Inc. | 2.86% | 18.00 | 0.0% | $17.86m | |
| AMRN | Amarin Corp. Plc | -0.81% | 1.84 | 1.5% | $8.41m | |
| EVOK | Evoke Pharma, Inc. | 1.64% | 3.10 | 39.7% | $8.15m | |
| USNA | USANA Health Sciences, Inc. | -0.58% | 72.48 | 4.2% | $5.42m | |
| BGXX | Bright Green Corp. | -3.59% | 2.42 | 0.0% | $4.30m | |
| ANIK | Anika Therapeutics, Inc. | 0.82% | 22.37 | 9.8% | $3.30m | |
| ATOS | Atossa Therapeutics, Inc. | 1.30% | 1.17 | 0.2% | $2.67m | |
| SMFL | Smart for Life, Inc. | 4.20% | 0.66 | 0.0% | $2.12m | |
| CDXC | Chromadex Corp. | -2.79% | 1.74 | 2.7% | $1.55m | |
| IBIO | iBio, Inc. | -1.28% | 0.28 | 0.2% | $1.18m | |
| NATR | Nature's Sunshine Products, Inc. | -3.69% | 10.57 | 0.4% | $0.85m | |
| FLGC | Flora Growth Corp. | -3.28% | 0.67 | 0.0% | $0.83m |
Company Profile
argenx SE operates as a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. It operates from the Netherlands, Belgium, the United States of America, Japan, Switzerland, Germany and France. The firm partnering with academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. It evaluates efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Breda, the Netherlands.